Record Orders and Backlog
Orders of $449 million in Q1 2026, a company record and a 97% increase year‑over‑year. Backlog reached a record $1.035 billion, up ~72% YoY and up $242 million sequentially (31%). Book-to-bill in the quarter was ~2.2x and trailing 12-month bookings were $1.286 billion (up 71% YoY).
Revenue Growth and Record Trailing 12‑Month Revenue
First quarter revenue of $206 million, up 17% year‑over‑year despite the sale of Global Pump Solutions (which reduced comparable prior‑year revenue by $14 million). Trailing 12‑month revenue was a record $804 million, up 32% YoY.
Adjusted EBITDA Acceleration
Adjusted EBITDA for Q1 was $20.4 million, up 46% YoY, representing approx. 10% EBITDA margin for the quarter. Trailing 12‑month adjusted EBITDA reached $96.7 million with a 12% margin (up ~160 bps YoY), and management expects to cross $100 million TTM adjusted EBITDA soon.
Very Large Sales Pipeline and April Momentum
Sales pipeline has grown to over $7 billion (management cited ~ $7.3B). April bookings alone exceeded $400 million and included the company's largest-ever order in the ~$300 million range, indicating continued momentum into Q2.
Raised Full‑Year Guidance
Standalone 2026 revenue guidance raised to $940 million–$1.0 billion (first time company may reach $1 billion in sales). Midpoint implies ~25% organic sales growth. Adjusted EBITDA guidance increased to $120 million–$140 million (midpoint ~44% EBITDA growth); management cites ~170 bps of expected margin expansion for the year.
Thermon Acquisition Progress and Synergy Outlook
Thermon transaction on track to close in early June (Q2). Management remains confident in previously outlined $40 million cost synergy target and is evaluating additional commercial synergies; combined run‑rate sales expected to be ~ $1.5 billion, with management aiming for Rule of 30/40 type performance over time.
SG&A Reduction and Operational Improvements (80/20)
SG&A decreased 14% YoY (down ~$7.5 million), an ~800 bps improvement as a percentage of revenue. Early Wave 1 of 80/20 implementation delivered initial benefits (primarily G&A) and is being scaled, with management expecting broader margin benefits as deployment expands.
Balance Sheet Capacity and Credit Amendment
Amended credit agreement increases committed capacity to $975 million ($740 million revolver + $235 million delayed draw term loan). Q1 gross debt $252 million (up ~$43 million from year‑end 2025) and management reports ~$723 million in capacity available to fund the Thermon cash consideration and growth needs.